Stocks
Intellia Therapeutics (NTLA) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -25.8% | -38.4% | -45.8% | -59.5% | -61.5% | -63.5% | ||
| Changes by years, y/y, % | 0pp | -13pp | -7pp | -14pp | -2pp | +19.3% | |||
Intellia Therapeutics. ROE, %
Intellia Therapeutics. ROE, changes, pp
Intellia Therapeutics (NTLA) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -67.4% | -67.1% | -59.6% | -61.5% | -63.5% | -63.5% | |
| Changes by years, y/y, % | -21pp | -15pp | -5pp | -2pp | +4pp | |||
| Changes by quarters, q/q, % | -8pp | +0pp | +8pp | -2pp | -2pp | |||
